10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||||||
| ||||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
AMGEN INC | |||
Ticker: AMGN Fiscal Year: 2017 | |||
Consolidated Statements of Cash Flows | |||
Period Ending Dec 31, 2017 10-K (Filed: Feb 13, 2018) | |||
| (In Millions, except shares in actual) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2017 | Dec 31, 2016 | Dec 31, 2015 | |
| Cash flows from operating activities: | |||
| Net income | $ 1,979 | 7,722 | 6,939 |
| Depreciation and amortization | 1,955 | 2,105 | 2,108 |
| Stock-based compensation expense | 329 | 311 | 322 |
| Deferred income taxes | (1,330) | 183 | (607) |
| Other items, net | 334 | 32 | (146) |
| Changes in operating assets and liabilities, net of acquisitions: | |||
| Trade receivables, net | (58) | (214) | (420) |
| Inventories | 133 | (80) | 481 |
| Other assets | (24) | (128) | 155 |
| Accounts payable | 424 | (44) | (12) |
| Accrued income taxes, net | 523 | (301) | 509 |
| Long-term tax liability | 6,681 | 445 | 409 |
| Other liabilities | 231 | 323 | (7) |
| Net cash provided by operating activities | 11,177 | 10,354 | 9,731 |
| Cash flows from investing activities: | |||
| Purchases of property, plant and equipment | (664) | (738) | (594) |
| Cash paid for acquisitions, net of cash acquired | (19) | 0 | (359) |
| Purchases of marketable securities | (33,607) | (28,094) | (25,977) |
| Proceeds from sales of marketable securities | 24,240 | 17,958 | 18,029 |
| Proceeds from maturities of marketable securities | 6,174 | 2,459 | 3,527 |
| Proceeds from sales of property, plant and equipment | 11 | 78 | 274 |
| Other | (159) | (321) | (447) |
| Net cash used in investing activities | (4,024) | (8,658) | (5,547) |
| Cash flows from financing activities: | |||
| Net proceeds from issuance of debt | 4,476 | 7,318 | 3,465 |
| Repayment of debt | (4,405) | (3,725) | (2,400) |
| Repurchases of common stock | (3,160) | (2,965) | (1,867) |
| Dividends paid | (3,365) | (2,998) | (2,396) |
| Settlement of contingent consideration obligations | 0 | 0 | (253) |
| Withholding taxes arising from shares withheld for share-based payments | (191) | (260) | (401) |
| Other | 51 | 31 | 81 |
| Net cash used in financing activities | (6,594) | (2,599) | (3,771) |
| Increase (decrease) in cash and cash equivalents | 559 | (903) | 413 |
| Cash and cash equivalents at beginning of year | 3,241 | 4,144 | |
| Cash and cash equivalents at end of year | 3,800 | 3,241 | 4,144 |
| External Links | |
| AMGEN INC (AMGN) Fiscal Year 2017 | |
| Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
| Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
| Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |